SEC Form 4 · accession 0001123292-18-000423
OSIRIS THERAPEUTICS, INC. · OSIR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Linda L Chang
Officer — Chief Financial Officer
Period of report
Feb 26, 2018
Accepted (ET)
Feb 28, 2018 · 10:34 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001360886
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $8.92 | Feb 26, 2018 | A | 20,000 | A | Feb 26, 2019 | Feb 25, 2028 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F15,000 shares underlying this option shall vest on each of February 26, 2019, February 26, 2020, February 26, 2021 and February 26, 2022, subject to Reporting Person's continued service through the applicable vesting date.